Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Here's Why Genomic Health Jumped Almost 15% Today

By Brian Orelli, PhD - Jul 24, 2019 at 5:43PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It had nothing to do with the underlying value of the company.

What happened

Shares of Genomic Health ( GHDX ) jumped 14.9% on Wednesday after the S&P Dow Jones Indices, a division of S&P Global ( SPGI -1.12% ), said the cancer test-maker would be joining the SmallCap 600 index. Genomic Health is replacing Electronics For Imaging, which was acquired by Siris Capital Group.

So what

Genomic Health won't actually be added to the index until Monday, but traders were clearly buying today in the hopes that the share price will be buoyed even more by exchange-traded funds and mutual funds that that will buy shares to match the makeup of the index.

This rally, and perhaps another on Friday or Monday, is likely to be short lived because it's related to the relative number of investors and traders who are interested in buying and selling shares, and doesn't have anything to do with the underlying value of the genetic test-maker.

Doctor showing a report to a patient in a hospital bed

Image source: Getty Images.

Now what

Genomic Health's ultimate value will be determined by its revenue and earnings, which should be released in the coming weeks. The company started out the year with a strong first quarter, but guidance implied a substantial slowdown in growth in the second half of the year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Genomic Health, Inc. Stock Quote
Genomic Health, Inc.
GHDX
S&P Global Inc. Stock Quote
S&P Global Inc.
SPGI
$455.82 (-1.12%) $-5.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
624%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/05/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.